ESC 365 - Why should I consider TMVR for my patient?

EHRA Premium Access

Why should I consider TMVR for my patient?

Session: Addressing the impact of mitral regurgitation in heart failure: the growing value of Transcatheter Mitral Valve Repair (TMVR)

Topic: Automatic implantable cardioverter / defibrillator

Speaker: Professor A. Vahanian (Paris, FR)

Sponsored by Abbott

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

About the speaker

Professor Alec Vahanian

Paris Cite University, Paris (France)

36 presentations

14 followers

4 more presentations in this session

Introduction - Addressing the impact of mitral regurgitation in heart failure: the growing value of TMVR.

Interplay between heart failure and mitral regurgitation and treatment impact.

Speaker: Professor M. Metra (Brescia, IT)

Who are the patients to refer to TMVR?

Speaker: Professor C. Butter (Bernau bei Berlin, DE)

Take home messages.

Speaker: Professor J. Bax (Leiden, NL)

Access the full session

Addressing the impact of mitral regurgitation in heart failure: the growing value of Transcatheter Mitral Valve Repair (TMVR)

Speakers: Professor A. Vahanian, Professor M. Metra, Professor C. Butter, Professor J. Bax

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by